These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effects of anti-inflammatory drugs following cataract extraction. Simone JN; Whitacre MM Curr Opin Ophthalmol; 2001 Feb; 12(1):63-67. PubMed ID: 11150083 [TBL] [Abstract][Full Text] [Related]
10. Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Brown RM; Roberts CW Insight; 1996 Apr; 21(1):13-6. PubMed ID: 8826226 [TBL] [Abstract][Full Text] [Related]
11. The Role of Steroids and NSAIDs in Prevention and Treatment of Postsurgical Cystoid Macular Edema. Grzybowski A; Kanclerz P Curr Pharm Des; 2018; 24(41):4896-4902. PubMed ID: 30727876 [TBL] [Abstract][Full Text] [Related]
12. Loteprednol etabonate 0.5% versus prednisolone acetate 1.0% for the treatment of inflammation after cataract surgery. Lane SS; Holland EJ J Cataract Refract Surg; 2013 Feb; 39(2):168-73. PubMed ID: 23232255 [TBL] [Abstract][Full Text] [Related]
13. Management of Postoperative Inflammation and Dry Eye After Cataract Surgery. Kato K; Miyake K; Hirano K; Kondo M Cornea; 2019 Nov; 38 Suppl 1():S25-S33. PubMed ID: 31498249 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study. Solomon KD; Vroman DT; Barker D; Gehlken J J Cataract Refract Surg; 2001 Aug; 27(8):1232-7. PubMed ID: 11524195 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Efficacy of Difluprednate 0.05% and Loteprednol Gel 0.5% After Cataract Surgery. Abessi B; Brooksby L; Schultze RL Eye Contact Lens; 2018 Nov; 44 Suppl 2():S37-S42. PubMed ID: 28628490 [TBL] [Abstract][Full Text] [Related]
16. Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation. Loteprednol Etabonate Post-operative Inflammation Study Group 1. Stewart R; Horwitz B; Howes J; Novack GD; Hart K J Cataract Refract Surg; 1998 Nov; 24(11):1480-9. PubMed ID: 9818338 [TBL] [Abstract][Full Text] [Related]
17. The role of perioperative nonsteroidal anti-inflammatory drugs use in cataract surgery. Brandsdorfer A; Patel SH; Chuck RS Curr Opin Ophthalmol; 2019 Jan; 30(1):44-49. PubMed ID: 30358619 [TBL] [Abstract][Full Text] [Related]
18. Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use. Amon M; Busin M Int Ophthalmol; 2012 Oct; 32(5):507-17. PubMed ID: 22707339 [TBL] [Abstract][Full Text] [Related]
20. A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2. Ophthalmology; 1998 Sep; 105(9):1780-6. PubMed ID: 9754192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]